About
Dengue Virus combined with autologous dendritic cells
Areas of Focus
Categories
Virus TechnologyStem Cell & Cellular TherapySan Diego & Southern California
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
30
By Phase
PHASE1: 3
By Status
UNKNOWN: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT03803397Lead Sponsor
Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanoma
PHASE1Unknown
10 participants
Started: Apr 1, 2024 · Completed: Dec 31, 2024
NCT03989895Lead Sponsor
Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With Melanoma
PHASE1Unknown
10 participants
Started: Apr 1, 2024 · Completed: Dec 31, 2024
NCT03990493Lead Sponsor
Intratumoral Injection of PV-001-DV Plus DC in Patients With Melanoma
PHASE1Unknown
10 participants
Started: Apr 1, 2024 · Completed: Dec 31, 2024
Locations (1)
Headquarters
Orange, CA, United States
Map
Loading map...